Jerusalem Pharmaceuticals Co. Ltd. reported consolidated unaudited earnings results for the year ended December 31, 2018. For the year, the company reported sales of USD 34,878,842 as compared to USD 35,154,346 for the same period last year. Net Income after tax was USD 6,095,827 as compared to USD 6,163,670 for the same period last year. Basic and diluted earnings per share was USD 0.346 as compared to USD 0.341 for the same period last year.